The limits of cost-effectiveness.
作者信息
Vladeck B C
出版信息
Am J Public Health. 1984 Jul;74(7):652-3. doi: 10.2105/ajph.74.7.652.
Abstract
摘要
相似文献
1
The limits of cost-effectiveness.成本效益的局限性。
Am J Public Health. 1984 Jul;74(7):652-3. doi: 10.2105/ajph.74.7.652.
2
Hospice care under Medicare--an early look.医疗保险下的临终关怀——初步观察。
Prev Med. 1990 Nov;19(6):730-6. doi: 10.1016/0091-7435(90)90071-q.
3
News from "the real world": cost-effectiveness in palliative care.“真实世界”的消息：姑息治疗中的成本效益
Support Care Cancer. 1994 Jul;2(4):211-2.
4
Hospice companies benefit from favorable Medicare rates.临终关怀公司受益于有利的医疗保险费率。
Health Care Strateg Manage. 2004 Jan;22(1):13-4.
5
1997 Medicare hospice benefit revisions: sounding off--a purely therapeutic exercise.1997年医疗保险临终关怀福利修订：发表意见——一项纯粹的治疗性举措。
Am J Hosp Palliat Care. 1998 Jan-Feb;15(1):4-6. doi: 10.1177/104990919801500101.
6
CMS responds to Medicare Hospice Benefit questions.
Caring. 2004 Aug;23(8):50-2.
7
A cost allocation model for hospice.临终关怀的成本分配模型。
Nurs Manage. 1993 Dec;24(12):38-41.
8
Medicare reimbursement for hospice care: an approach for analyzing cost consequences.医疗保险对临终关怀的报销：一种分析成本后果的方法。
Inquiry. 1986 Summer;23(2):141-53.
9
GAO: Modification of Medicare hospice payments "may be warranted".
Caring. 2004 Nov;23(11):60-1.
10
Simulating the impact of case-mix adjusted hospice rates.模拟病例组合调整后的临终关怀费率的影响。
Health Care Financ Rev. 1986 Winter;8(2):53-64.
本文引用的文献
1
What does hospice cost?临终关怀的费用是多少？
Am J Public Health. 1984 Jul;74(7):689-97. doi: 10.2105/ajph.74.7.689.
Zotero 插件